Objective: Neointimal hyperplasia remains a principal cause of vein graft failure. Genetic contributions to vein graft neointimal hyperplasia could be well studied in the mouse; however, surgical approaches to vein bypass surgery in the mouse have yet to replicate approaches commonly employed in human patients. Consequently, the goal of this study was to develop a murine interposition vein graft model that reproduces characteristics of human vein graft disease. Method: Using C57BL/6J mice, we excised inferior venae cavae (IVCs) from donor mice and grafted them, with end-to-side anastomosis, into the carotid circulation of recipients. IVC grafts were harvested from 3 to 56 days postoperatively, and analyzed for the development of neointima and media. Results: Thickening of both the vein graft neointima and media progressed rapidly between postoperative weeks 1 and 4, and reached steady state levels by approximately week four, with a graft-wall thickness of 91 ؎ 4 m (14 cell layers), a lumen area of 0.56 mm 2 , an average neointima-media ratio of 0.4 to 0.6, and a predominance of ␣-smooth muscle actin-staining cells. Comprising predominately smooth muscle actin-expressing cells, the neointima was 50% thicker in the proximal than in the distal third of the grafts (P < .001), but proximal and distal vein graft anastomoses were widely patent.
Arterial bypass graft surgery with autologous vein conduits results in neointimal hyperplasia during the process of vein graft arterialization. 1 Involving smooth muscle cell (SMC) proliferation and migration into the intima as well as extracellular matrix synthesis, 2 neointimal hyperplasia remains a major obstacle to long-term patency of venous bypass grafts. 1 Despite refinements in surgical technique, the rate of saphenous vein graft failure remains high: up to 30% of vein grafts become stenotic and require intervention within 2 years because hemodynamically significant neointimal hyperplasia develops. 3 By 10 years, the rate of vein graft closure may be as high as 50%, 1, 2, 4, 5 largely from accelerated atherosclerosis that arises from the initial vein graft neointimal hyperplasia. 1, 6 Control of vein graft neointimal hyperplasia has, therefore, motivated many experimental and clinical trials. [7] [8] [9] Pathogenic factors important in the development of vein graft neointimal hyperplasia remain incompletely un-derstood. To study the gene products important in arterial neointimal hyperplasia, a number of investigators have begun to use the mouse as an experimental system because of the wealth of targeted gene deletions that have been created in mice. 10, 11 To engender neointimal hyperplasia, these studies have employed a variety of arterial endothelial 12 or adventitial 13, 14 injury approaches, as well as arterial ligation. 15, 16 To study neointimal hyperplasia in murine vein grafts, rather than arteries, previous studies have avoided end-to-side graft anastomoses by employing arterial cuffs that facilitate technically simple ligation of the vein graft to the transected artery. 17, 18 Thus, these studies cannot assess the important contribution to vein graft pathology of neointimal hyperplasia at the sites of end-to-side anastomoses, where most human saphenous vein grafts tend to fail first. 3, 19, 20 To model human venous bypass surgery more faithfully in the mouse, we have performed a series of carotid interposition vein grafts with end-to-side anastomoses in the C57BL/6J inbred mouse strain. In this study, we characterize the evolution of these vein grafts morphologically, to the point of steady state graft wall thickness.
METHODS

Mice.
Adult male C57BL/6J mice weighing 17 to 20 g were purchased from The Jackson Laboratory (Bar Harbor, Me). The animals were maintained on a 12-hour light-dark cycle, and received water and chow ad libitum. All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Commit-tee and complied with the Guide for the Care and Use of Laboratory Animals (National Research Council).
Vein graft surgery. All operative procedures were performed aseptically, with pentobarbital sodium (50 mg/kg body weight, intraperitoneal) anesthesia, using an operating microscope (WECK Model 029001 [zoom 3.6-18ϫ], J. K. Hoppl Corporation). A 1-cm segment of inferior vena cava (IVC) was harvested from a donor mouse and anastomosed to a syngeneic recipient's carotid artery. For IVC preparation, bilateral subcostal incisions were made in the donor mouse. The anterior chest wall was separated from the diaphragm, and the anterior rib cage was divided with heavy scissors on both sides of the sternum from the lower rib margins to the clavicles. The resulting hinged thoracic door was lifted to expose the heart and IVC. The IVC adventitia was removed, and, starting at the right atrium, a 1-cm length of IVC was excised and washed with lactated Ringer's solution containing 50 U/mL heparin; subsequently, the IVC was stored in this heparinized solution at 25°C until it was transplanted. In the graft recipient mouse, the right common carotid artery was exposed by ventral midline incision from the lower mandible to the sternum. Subsequently, from its take-off from the brachiocephalic to its bifurcation, a 15-mm segment of the carotid artery was isolated. This segment of common carotid artery was then gently occluded proximally and distally with 5-0 silk suture. Next, two arteriotomies (about 2-mm long) were created proximally and distally, 0.8 to 1 cm apart, with a bent 28-gauge needle and a Vannas angled scissors (Roboz Surgical, Inc, Rockville, Md) ( Fig 1) . The carotid artery was then flushed with heparinized (50 U/mL) saline through the arteriotomies. End-to-side anastomosis between the IVC and carotid was performed with 11-0 nylon (Ethicon, Inc, Somerville, NJ), using two fixed sutures at the proximal and distal corners of each arteriotomy, and two running sutures, each 180°around the circumference (with 4-6 bites/180°). The carotid segment between the IVC anastomoses was ligated at both ends and cut, thereby stretching the IVC graft. The 5-0 silk ligatures were then removed from the proximal and distal common carotid, and patency of the transplanted IVC graft was confirmed by observing blood flow through the wall of the turgid graft. The incision was then closed in two layers with running 5-0 silk sutures. Operative time averaged 20 minutes for IVC harvest and 90 minutes for carotid interposition grafting.
IVC graft ultrasonography. Mice were imaged with a Hewlett Packard Sonos 5500 equipped with a 0.8 x 3 cm transducer (Agilent Technologies) used at a frequency range of 7 to 15 MHz. To avoid extrinsic graft compression, we placed anesthetized mice in a water bath and imaged with the transducer held 2 to 10 mm from the skin. Ultrasound settings were maximized for pulse repetition frequency (depth 2 cm, scale factor 3.3 cm/sec). Two-dimensional and color-flow Doppler im-ages were obtained at a frame rate of 22 Hz. We could not reliably identify the vein graft anastomoses by use of ultrasound.
IVC graft harvest and histology. From 3 days to 8 weeks postoperatively, mice were anesthetized, as above, for IVC graft harvest. The graft was exposed through the previous surgical incision, and the thoracic cavity was opened. The right atrium was incised, and the graft was perfused with phosphate buffered saline by placement of a 22-gauge butterfly angiocatheter in the left ventricle. The graft was subsequently perfusion-fixed in situ with 10% buffered formalin for 20 minutes at a constant pressure of 100 mm Hg. To facilitate orientation of the graft during paraffin embedding, we excised the aortic root and arch along with the right common carotid, the IVC graft, and the right carotid bifurcation (Fig 2, B) . The graft was subsequently placed into 10% neutral buffered formalin for 24 hours, and then transferred to 70% ethanol until paraffin embedding could be accomplished (Յ72 hr). Remnants of the suture used for anastomosis were employed to orient the specimen in a vertical position at the time of embedding, thus facilitating cross-sectioning. Sections of 4 m were subjected to staining with hematoxylin and eosin, as well as a modified Masson's trichrome and Verhoeff's elastic tissue stain, which facilitates the simultaneous identification of collagen (green), elastin (black), cytoplasm (red), and nuclei (black). 21 Unless otherwise indicated, IVC sections for morphometric analysis were obtained 0.5 mm from the distal anastomosis. We quantitated nuclear density on enlarged color prints of hematoxylin and eosin-stained sections, using a grid of 50 ϫ 50 m squares.
Immunohistochemistry. Serial sections adjacent to the hematoxylin and eosin-stained sections were processed for routine immunoperoxidase staining with the anti-␣smooth muscle cell actin immunoglobulin (IgG) clone 1A4 (Sigma, Inc). Briefly, sections were de-paraffinized, rehydrated, and treated with 0.6% hydrogen peroxide in methanol with subsequent water rinse, to quench endogenous peroxidase activity. Specimens were then incubated (30 minutes) with Background Buster (Innovex Biosciences, Inc, Richmond, Calif) to reduce nonspecific IgG binding. Subsequently, sections were incubated (25°C) serially with 1A4, anti-mouse/biotin, and streptavidin/horseradish peroxidase, each in 2% bovine serum albumin (BSA)/ phosphate-buffered saline (PBS) for 30 to 60 minutes, with multiple washes between incubations. Finally, sections were developed with Vector Red (Vector Labs, Inc, Burlingame, Calif) for 3 minutes, counterstained with hematoxylin, dehydrated, and mounted with Permount (Fisher, Pittsburgh, Pa). For negative control vein graft sections, incubation with 2% BSA/PBS was substituted for the 1A4 incubation. The positive control for 1A4 was mouse small intestine. All specimens were run simultaneously, and negative controls yielded no immunoperoxidase reaction (data not shown).
Morphometry. Morphometric analyses were performed on tissue stained with the modified Masson's trichrome and Verhoeff's elastic tissue stain. 21 Images of 55ϫ original magnification were captured using an RT SPOT CCD camera (Diagnostic Instruments, Inc, Sterling Heights, Mich). Perimeter and area measurements for the lumen, neointima, and media were performed by planimetry using Scion Image (Scion Corp, Frederick, Md). These measurements were then used to create concentric circles of area or perimeter equivalent to that measured directly from the vein graft sections, and the radii of these circles were used to calculate the average thickness of each graft layer (Fig E1, online only) . Perimeter rather than area measurements were ultimately used to calculate graft layer radii, given that several of the grafts harvested at early time points failed to hold their cylindrical geometry during fixation and embedding, and perimeter measurements provided supe- rior reproducibility, especially for these specimens. Neointima was recognized both by the criss-cross, random-appearing orientation of the smooth muscle cells, and by its predominantly red color, imparted by the prevalence of SMC cytoplasm and relative paucity (as compared with the media) of collagen. 22 Media was recognized by both the circular orientation of the SMCs and the green color imparted by the prevalence of dense collagen. 22 Adventitia was recognized by the presence of both vasa vasorum and loose connective tissue. 22 To quantitate smooth muscle actin as a percentage of the graft wall, we used planimetry to measure the area comprising total graft wall and that comprising ␣-smooth muscle actin-staining portions of the graft wall.
Data analysis. Average thicknesses for each vein graft layer were calculated by assuming a circular geometry for each layer, and calculating the radius of the circle corresponding to the relevant perimeter (subtended by the endothelium [lumen perimeter], neointima/media border, and media/adventitia border). 22 For each IVC specimen, morphometric measurements were performed on a single representative section. For each time-point, data from the indicated number of independent IVC specimens (n ϭ 3-8) were averaged, and this average Ϯ standard error (SE) is presented in all figures. Statistical comparisons among independent means, when performed, were carried out by one-way analysis of variance with Tukey post-hoc test for multiple comparisons (GraphPad Prism).
RESULTS
A view of the operating field at the end of interposition grafting is found in Fig 2, A, with arrows indicating the location of the anastomoses between the IVC graft and the common carotid artery. Fig 2, B , depicts a vein graft after fixation and explantation, with arrows indicating the positions of the proximal and distal common carotid, as well as the aortic arch. The sutures at the anastomoses are clearly visible, and delineate the margins of the vein graft. The external diameters of the IVC graft (with associated connective tissue) and the carotid can be visualized in Fig 2, B . The ratio of IVC to carotid internal diameters was 2.3 Ϯ 0.3 (n ϭ 3). To assess whether blood flow in the vein grafts was laminar, we subjected mice to ultrasound scanning 3 to 6 weeks postoperatively. By color-flow Doppler ultrasonography (Fig 2, C) , blood flow through the body of the vein grafts was laminar (n ϭ 3). Twenty-eight mice were analyzed for our morphologic study, with vein grafts harvested postoperatively at 3 days (n ϭ 3), 1 week (n ϭ 4), 2 weeks (n ϭ 4), 4 weeks (n ϭ 5), 6 weeks (n ϭ 8), and 8 weeks (n ϭ 4). The overall perioperative mortality in this initial cohort was 25%, and the surgical success rate (ie, the prevalence of patent grafts at the time of harvest) was 80%. (However, mortality and success rates among the next 40 mice operated were Յ10% and Ͼ95%, respectively.) The perioperative deaths were related to either anesthesia or hemorrhage, and graft failures resulted from luminal thrombosis.
To determine the time course of IVC arterialization and neointimal hyperplasia in this murine model, we harvested IVC-to-carotid grafts at postoperative weeks 0.5, 1, 2, 4, 6, and 8, and examined cross sections of the graft 0.5 mm proximal to the distal anastomosis (Fig 3) . IVC graftwall thickness-defined as the sum of medial and neointimal thickness-increased approximately ten-fold through postoperative week 4, and then appeared to stabilize at 91 Ϯ 4 m (Fig 3, B) , or 14 cell layers (Fig 3, C) . The ratio of neointimal thickness to medial thickness ranged from 0.4 to 0.6, both at 4 weeks and 6 weeks postoperatively. As IVC graft arterialization proceeded, luminal area appeared to decrease over the first two postoperative weeks, and then stabilize at 0.56 Ϯ 0.08 mm 2 (Fig 3, D) . Thus, arterialization of the IVC graft in this model resulted in not only a ten-fold increase in graft-wall thickness, but also a (statistically insignificant) 16% reduction in luminal area.
To assess vein graft maturation further in this model system, we measured the change with time in the number of nuclei and smooth muscle cells per unit area of vein graft wall. Because arterialization of vein grafts includes hyperplasia and hypertrophy of SMCs as well as extracellular matrix secretion, 2 stabilization of vein-graft wall cellular density might be expected to precede stabilization of veingraft wall thickness. In a qualitative way, this expectation appears to be realized in this model: although nuclear (cellular) density plateaud at 4 weeks postoperatively ( Fig  4) , vein-graft wall thickness tended to peak at 4 weeks and decline slightly thereafter (perhaps reflecting progressive remodeling of the extracellular matrix). Congruently with the increase in graft nuclear density, SMC actin-positive cells increased to a steady state 45% of total graft wall area, also by 4 weeks postoperatively (Fig 4, B) . Thus, as in other vein graft systems, 2 the preponderance of neointimal and medial cells in this murine model appear to be SMCs or "myofibroblasts." 23 Fixation of the IVC graft specimens that facilitates cross-sectional analysis of the body of the graft results in oblique sectioning of the anastomoses between the IVC and the carotid. As a result, we cannot quantitate the luminal and graft wall areas at the anastomoses precisely. Nonetheless, because anastomotic stenoses frequently produce vein graft failure 3, 19, 20 we examined each of the IVC graft anastomoses qualitatively ( Fig 5) . As demonstrated in Fig 5 , IVC grafts demonstrated wide anastomotic patency at each of the indicated time-points (data for 0.5, 1, 4, and 8 weeks not shown).
Either turbulent blood flow, 24 excess growth factor secretion, 19 or both phenomena near vein graft anastomoses may increase neointimal hyperplasia at these sites, or create variability in the extent of neointimal hyperplasia across the length of the graft. To assess these possibilities in our vein graft model, we studied cross sections of mature vein grafts, spaced at 0.5-mm intervals across the entire length of each graft (Fig 6) . Fig 6, A, shows a single cross section from a vein graft harvested 6 weeks postoperatively. In averaging findings from three vein grafts harvested 6 weeks postoperatively, we found substantial similarity in the neointimal and medial thicknesses of cognate cross sections from the three specimens examined (Fig 6, B) . By dividing the grafts into proximal, middle, and distal thirds, however, we found the neointimal thickness ( Fig 6, C and  D) was 50 Ϯ 20% greater in the proximal third than in the distal third (P Ͻ .001)-consistent with the idea that turbulent flow may predominate more in the proximal than in the distal graft segments. However, within each of the proximal, middle, and distal thirds of the grafts, there is remarkable similarity of neointimal thickness among cross sections. Indeed, the coefficient of variation on neointimal thickness among graft cross sections within 1.5 mm of each other ranged from 12% (distal third) to 29% (middle third). Congruent with the neointimal measurements, medial thickness in the proximal as well as middle graft segments was also greater than that of the distal segment (by 25%-33%, P Ͻ .001), and medial thickness measurements also demonstrated high reproducibility within segments (Fig 6,  C and D) . Thus, this vein graft model would facilitate comparison of neointimal hyperplasia among distinct vein grafts: as long as distinct grafts are compared using cross sections from anatomically similar graft segments (proximal, middle, or distal), the variation in neointimal or medial hyperplasia attributable to graft sectioning appears small enough to facilitate meaningful comparisons among grafts subjected to different treatments or derived from genetically different mice.
DISCUSSION
With a syngeneic mouse IVC-to-carotid interposition vein graft system, we have shown that neointimal hyperpla- sia and medial thickening develop rapidly, and stabilize by about 4 weeks postoperatively with regard to graft-layer thickness, nuclear density, luminal area, and graft-wall composition measured by either the number of cell layers or percentage of SMCs. Moreover, we have shown that both neointimal and medial thickness are asymmetrically distributed along the length of the IVC graft, and that they appear most pronounced within the proximal third (neointima) to two thirds (media) of the graft. In our chow-fed mice, neointimal hyperplasia did not significantly encroach on the lumen of the vein graft.
In comparing our murine vein graft model with human vein grafts, several points should be considered. First, the diameter of our IVC grafts is 2.3-fold larger than that of the carotid artery to which they are grafted. Although such a size discrepancy would be unusual in peripheral arterial grafting, it would not be unusual in aortocoronary bypass grafting: saphenous vein segments measuring between 3.5 and 6 mm in diameter can be anastomosed to coronary IVC graft cellular density and smooth muscle composition stabilizes by the fourth postoperative week. IVC grafts harvested at the indicated number of weeks were serially sectioned and stained either with modified connective tissue stain (Fig 3, A) , with hematoxylin and eosin (H&E), or with immunoperoxidase for alpha-smooth muscle cell (␣-SMC) actin (panel A). A, representative photomicrographs (original magnification, ϫ1100) demonstrating hematoxylin-stained cellular nuclei (note the prevalence of inflammatory cell nuclei in the 2-week specimen) (H&E), or reddish brown precipitate specific for ␣-SMC actin. Photomicrographs depict media and neointima only. B, Cell nuclei (left axis) were counted within a template measuring 2.5 ϫ 10 3 m 2 , at four random points within each graft cross section examined. Plotted are the mean Ϯ SE of measurements made from two grafts at each time point. SMC Actin (right axis): The percentage of vein graft wall area comprising SMCs was quantitated by planimetry. Shown are the means Ϯ SE of calculations from three grafts at each time-point. arteries with diameters as small as 1.5 to 2 mm. 25 Second, neointimal hyperplasia in the mouse IVC grafts demonstrated a juxta-anastomotic predominance (in the proximal third of the graft), much like that reported for human peripheral saphenous vein grafts. 3, 26 Thus, the turbulent blood flow and/or compliance mismatch between artery and vein graft believed to engender juxta-anastomotic lesions in human grafts 3, 26, 27 appears to affect our murine IVC grafts similarly. Moreover, because the extent of neointimal hyperplasia correlates inversely with laminar shear stress, 24, 27, 28 the relative attenuation of neointimal hyperplasia in the distal two thirds of our IVC grafts suggests that laminar shear stress increases along the length of our grafts. Third, in our syngeneic mouse vein graft transplants, as in vein grafts of human 1 and other animal models, 2 the neointimal hyperplastic response involves predominately ␣-smooth muscle actin-stainable, myointimal cells. Lastly, like the myointimal hyperplasia observed in human aortocoronary 1 and other animal-model 2 vein grafts, neointimal hyperplasia in our mouse IVC grafts failed, even at steady state, to produce significant luminal stenosis. Taken together, these points make a case for biologic similarity between human vein grafts, or other animal model vein grafts, and our murine vein graft model. Because of this similarity, results obtained with our murine model could plausibly provide mechanistic insights relevant to human vein graft neointimal hyperplasia.
Unlike our murine IVC-to-carotid graft system, the first such system to be reported 17 avoided direct anastomosis of the vein to the artery. Rather, Zou et al ligated the IVC to the common carotid artery with the use of polyethylene 17 or nylon 18 tubing "cuffs" placed on the cut ends of the common carotid artery. As a result, Zou et al were unable to study potential heterogeneity of neointimal hyperplasia engendered by the standard end-to-side anastomosis employed in this study. It is of interest that the system described by Zou et al differed substantially from our system in other, quantitative aspects. Zou et al found the total wall thickness of mature vein grafts to be as much as 20 cell layers, or 200 m. By contrast, we found corresponding values in mature vein grafts of only as much as 14 cell layers, or 90 m. Moreover, whereas our system demonstrated stabilization of vein graft wall thickness by 4 weeks (much like rabbit autologous jugulocarotid grafts 29 The proximal third of mature IVC grafts demonstrates augmented neointimal hyperplasia. Three IVC grafts harvested 6 weeks postoperatively were sectioned at 0.5-mm intervals along their entire length, starting 0.5 mm proximal to the distal anastomosis. Each section was stained with a modified connective tissue stain (see Methods). A, A representative cross section from a single IVC graft is pictured, with multiple vasa vasorum visible in the adventitia (and a representative vas vasorum highlighted by the arrow). Scale bar indicates 200 m. B, Neointimal and medial thicknesses were calculated morphometrically for each graft at the indicated distances from the distal anastomosis, and the mean Ϯ SE (n ϭ 3) are presented ("total wall" ϭ media plus neointima). C, Each of the three grafts was divided into thirds (comprising four cross sections); the mean Ϯ SE for average neointimal or medial thickness within the indicated graft tertile is plotted. Compared with the distal third of the graft: *P Ͻ .001. D, A representative photomicrograph from a single graft cross section stained with the modified connective tissue stain, demonstrating the delineation of neointima, media, and adventitia (see Methods). Scale bar indicates 50 m (original magnification, ϫ1100).
observe what is likely more exuberant neointimal hyperplasia than what we observe.
These important differences between our vein graft system and that devised by Zou et al 17 almost certainly derive from differences in the surgical approaches of the two systems, given that both systems share the same mouse genetics, graft source, and artery grafted. The most obvious difference between the two systems lies in the use of endto-side anastomoses in our system and the use of arterial cuffs by Zou et al. Other differences may also be pertinent. For example, limiting the extent of hemodynamically induced vein graft expansion with external stenting has been shown to reduce neointimal hyperplasia. 30 Potential differences in wound closure could create differences in effective external support of the vein grafts placed in these investigations, and thereby engender differences in vein graft neointimal hyperplasia.
A chief advantage of the murine IVC graft approach presented here is that, in this system, neointimal hyperplasia reaches steady state morphology by postoperative week 4, and thereby can facilitate relatively short-term intervention or genetic studies. In addition, because the neointimal hyperplasia in this model is only moderate in degree, one could expect to perform experiments in which one could observe either increases or decreases in the extent of vein graft neointimal hyperplasia. Ultimately, use of this model to determine genetic influences on neointimal hyperplasia will involve transplanting IVCs from not only wild type (control) mice but also gene-deleted or transgenic mice, congenic (genetically identical except for the targeted gene alteration) to the C57BL/6J inbred strain. For this purpose, our model affords an important potential benefit that can easily be confirmed by serial sectioning of the vein grafts. If mutant and wild type graft sections are taken from cognate graft segments (proximal, mid, or distal thirds), differences in neointimal hyperplasia observed between mutant and wild type grafts will likely be attributable to their genetic differences, rather than to heterogeneity of neointimal hyperplasia within cognate graft segments.
